articleScienceNov 14, 2014GREEN OA

An oncogenic super-enhancer formed through somatic mutation of a noncoding intergenic element

Harvard University · Dana-Farber Cancer Institute · +8 more institutions

PubMed
Indexed incrossrefpubmed

Abstract

In certain human cancers, the expression of critical oncogenes is driven from large regulatory elements, called super-enhancers, that recruit much of the cell's transcriptional apparatus and are defined by extensive acetylation of histone H3 lysine 27 (H3K27ac). In a subset of T-cell acute lymphoblastic leukemia (T-ALL) cases, we found that heterozygous somatic mutations are acquired that introduce binding motifs for the MYB transcription factor in a precise noncoding site, which creates a super-enhancer upstream of the TAL1 oncogene. MYB binds to this new site and recruits its H3K27 acetylase-binding partner CBP, as well as core components of a major leukemogenic transcriptional complex that contains RUNX1,…

No related works found for this paper.